CHM chimeric therapeutics limited

Ann: CHM 1101 data accepted for presentation at SNO meeting, page-96

  1. 49 Posts.
    lightbulb Created with Sketch. 86
    This is because they are not using RECIST which uses the definition of a Partial Response being a 30% decrease in tumour size. https://project.eortc.org/recist/wp-content/uploads/sites/4/2015/03/RECISTGuidelines.pdf.

    The trial is using the Response Assessment in Neuro-Oncology Criteria (RANO) criteria, which states a Partial Response is a 50% or more decrease of all measurable enhancing lesions.
    https://radiopaedia.org/articles/rano-criteria-for-glioma
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
0.4¢
Change
0.000(0.00%)
Mkt cap ! $8.060M
Open High Low Value Volume
0.4¢ 0.4¢ 0.4¢ $20.21K 5.053M

Buyers (Bids)

No. Vol. Price($)
2 2213046 0.4¢
 

Sellers (Offers)

Price($) Vol. No.
0.5¢ 13563373 20
View Market Depth
Last trade - 15.01pm 24/06/2025 (20 minute delay) ?
CHM (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.